Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
ConditionPruritis
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAkron Children's Hospital
About this trial
The goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Eligibility criteria
Qualifiers
None
Disqualifiers
Currently taking Dupixent for any other diagnosis
known allergy to Dupixent
pregnant and or lactating mothers
anyone treated for pruritus using laser therapy
Trial design
Treatments tested in this trial
- Dupilumab
- Placebo
Treatment groups
46 Participants
are divided into 2 treatment groupsSponsors and collaborators
Akron Children's Hospital
Lead sponsor
Regeneron Pharmaceuticals
Collaborator
Ohio State University
Collaborator
Source ClinicalTrials.gov